Get started
Microbot Medical Inc.Microbot Medical Inc.Microbot Medical Inc.

Microbot Medical Inc.

No trades
See on Supercharts
Overview Financials News
Ideas
Discussions Technicals Forecast Seasonals Options

MBOT trade ideas

MBOT | Great Entry Point | LONGMicrobot Medical Inc., a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company, through its ViRob, TipCAT, CardioSert, and Liberty micro-robotic technologies, developing Self Cleaning Shunt for the treatment of hydrocephalus and normal pressure hydrocephalus; a disposable robot for various endovascular interventional procedures; and a multi generation pipeline portfolio. It has 42 issued/allowed patents and 23 patent applications pending worldwide. The company has a strategic collaboration agreement with Stryker Corporation for technology co-development. Microbot Medical Inc. was founded in 2010 and is based in Hingham, Massachusetts.
NASDAQ:MBOTLong
by DivergenceSeeker
MBOT Stock Breakout!Hi, this is my first time here I'm just a beginner in day trading on stocks and I want to share my ideas about the simple resistance/support levels strategy. Although I see a flag pattern and a nearly breakout coming specially if it won't break the 3 support levels. on the other hand if it did a touch on the down trendline with a pullback it will be a very bullish sign. Again I'm just a beginner who wants to apply what he learns, I will be appreciated if someone discussed this technical analysis with me! Thanks.
NASDAQ:MBOT
by Kuroko8
MBOT - Submarine taking breath?Microbot is a interesting company with interesting patents on micro robotic medicals. Even more than 30 are granted another 20 are pending. Further more information see on there homepage. Meanwhile MBOT has done a hugh consolidation. OBV looks great on long time, but on daily view seems no so bright: Means backtesting expected. BUT: Should we take the zone around 13.50 on weekly closing, expext rocket to around 35-47 USD per share. Now- be patient until 13.50 is broken.
NASDAQ:MBOT
by Flyerdan
Disposable Surgical Robotic Device - BIG News Coming 8/17/20Microbot Medical Inc., a pre-clinical medical device company, researches, designs, and develops micro-robotics assisted medical technologies targeting the minimally invasive surgery space. The company, through its ViRob, TipCAT, and Liberty micro-robotic technologies, developing Self Cleaning Shunt for the treatment of hydrocephalus and normal pressure hydrocephalus; a disposable self-propelled locomotive device to treat capabilities within tubular lumens, such as the blood vessels, respiratory, and the urinary and GI tracts; a combination of a guidewire and microcatheter technologies that are used for endoluminal surgery; and maneuver guidewire, microcatheters, and over-the-wire devices within the body's vasculature. It has 37 issued/allowed patents and 15 patent applications pending worldwide. Microbot Medical Inc. was founded in 2010 and is based in Hingham, Massachusetts. Microbot Medical to Share Current Results of a Feasibility Animal Study Utilizing the LIBERTY Robotic System Results to be shared on August 17th during Needham’s Virtual Med Tech & Diagnostics Conference HINGHAM, Mass., Aug. 13, 2020 (GLOBE NEWSWIRE) -- At the upcoming Needham Virtual Med Tech & Diagnostics Conference, being held on Monday, August 17, 2020, Microbot Medical Inc. (Nasdaq: MBOT), will provide initial results of a feasibility animal study performed using the Company’s LIBERTY Robotic System. finance.yahoo.com On 1/13/20, H.C. Wainwright maintained a Buy rating on MBOT and raised the price target from $12 to $26.00. I think this device could be a game changer. Disposable medical devices is where the future is going especially for sanitary reasons. Watch this stock Monday, 8/17/2020, it could run hard. I think the stock has been consolidating for a while and is coiling and ready to explode higher. Long! DISCLAIMER The Content herein is for informational purposes only, you should not construe any such information or other material as legal, tax, investment, financial, or other advice.
NASDAQ:MBOTLong
by HotCharts
Microbot Medical Inc turning Bullish Microbot Medical, Inc. is a pre-clinical medical device company, which engages in the research, design, development, and commercialization of micro-robotics assisted medical technologies. The firm carries out its operations through the ViRob and TipCat platforms. The ViRob platform technology is an autonomous crawling micro-robot that can be controlled remotely or within the body. It makes use of the Self-Cleaning Shunt, a robotic system designed as the ventricular catheter portion of a Cerebrospinal Fluid shunt system, and is mainly used for the treatment of hydrocephalus and Normal Pressure Hydrocephalus. The TipCat platform, a self-propelling, flexible, and semi-disposable endoscope provides see-and-treat capabilities within tubular lumens in the human body such as the colon, blood vessels, and the urinary tract. The company was founded by Harel Gadot, Moshe Shoham, and Yosseph Bornstein on August 2, 1988 and is headquartered in Hingham, MA.
NASDAQ:MBOTLong
by DEXWireNews
$MBOT Traders increasing attention in Pre-Clinical Robotics CO*********This is truly speculative as there is no fundamental reason for this to be attracting attention, but it could very likely spike in the coming days. This is a pre clinical company so news has a major impact on price.***** COMPANY PROFILE Microbot Medical, Inc. is a pre-clinical medical device company, which engages in the research, design, development, and commercialization of micro-robotics assisted medical technologies. The firm carries out its operations through the ViRob and TipCat platforms. The ViRob platform technology is an autonomous crawling micro-robot that can be controlled remotely or within the body. It makes use of the Self-Cleaning Shunt, a robotic system designed as the ventricular catheter portion of a Cerebrospinal Fluid shunt system, and is mainly used for the treatment of hydrocephalus and Normal Pressure Hydrocephalus. The TipCat platform, a self-propelling, flexible, and semi-disposable endoscope provides see-and-treat capabilities within tubular lumens in the human body such as the colon, blood vessels, and the urinary tract. The company was founded by Harel Gadot, Moshe Shoham, and Yosseph Bornstein on August 2, 1988 and is headquartered in Hingham, MA.
NASDAQ:MBOT
by DEXWireNews
Recent Study Validates the Operational EffectivenessIn addition to this study, the Company previously announced data from two pre-clinical studies that were performed at leading U.S. academic institutions: -In-vitro study, which was performed at Wayne State University, supports the SCSTM’s potential as a viable technology for preventing occlusion in shunts used to treat hydrocephalus. -In-vivo animal study, which was performed at Washington University School of Medicine in St. Louis, supports the safety profile of the Company’s SCSTM as a CSF catheter. The primary and secondary endpoints will seek to validate the safety and efficacy of the SCSTM that will be activated in both in-vitro (lab) and in-vivo (animal) models. The Company’s objective is to conclude the follow up study and announce the data in the second half of 2019. The Company plans to use the findings either for its regulatory submissions in the US, Europe and other jurisdictions, or as part of a pre-submission meeting request, depending on the final results of the ongoing follow-up study. www.microbotmedical.com
NASDAQ:MBOTEducation
by AlenCiken